Ab­b­Vie's Phar­ma­cyclics files patent suit against BeiGene over BTK ri­val Brukin­sa

Phar­ma­cyclics is bring­ing its BTK bat­tle to court.

The Ab­b­Vie unit filed suit against BeiGene on Tues­day, al­leg­ing the com­pa­ny’s com­pet­ing blood can­cer drug Brukin­sa …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER